Skip to content

Clinical trials

Phase 3 Ovarian Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 3 Country / region: South Korea Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20071
20093
20101
20121
20133
20154
20163
20171
20183
20194
20202
20213
20223
20232
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting14
Recruiting10
Completed8
Terminated7
Unknown status5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca7
Merck Sharp & Dohme LLC4
Pfizer4
National Cancer Institute (NCI)3
AbbVie2
Amgen2
GlaxoSmithKline2
National Cancer Center, Korea2
Novartis Pharmaceuticals2
Seoul National University Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms45
Fallopian Tube Neoplasms22
Carcinoma, Ovarian Epithelial6
Peritoneal Neoplasms5
Brenner Tumor2
Neoplasms2
Adenocarcinoma, Clear Cell1
Adenocarcinoma, Mucinous1
Adenomyosis1
Breast Neoplasms1

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.